Tektrotyd is a SPECT/CT alternative for diagnosing GEP-NET tumours that overexpresses somatostatinreceptors. It is a kit for the radiopharmaceutical preparation of 99mTc.

Delivered to
Questions about expiration date & durability?


Kit for the preparation of 99mTc-TEKTROTYD used for intravenous injection after radiolabelling with sodium 99mTc pertechnetate solution and is indicated for diagnostics of pathological lesions in which somatostatin receptors are overexpressed (particularly subtype 2 and, to a less extent, subtypes 3 and 5).

In particular, these are:

  • Gastro-entero-pancreatic neuroendocrine tumours (GEP-NET)
  • Pituitary adenomas
  • Tumours originating in a sympathetic system; pheochromocytoma, paraganglioma, neuroblastoma, ganglioneurinoma etc.
  • Medullary thyroid carcinoma

This kit is a registered pharmaceutical since 2016.

Information for HCP

Follow the link to your local SmPC

Link to SmPC in Denmark
Link to SmPC in Finland
Link to SmPC in Norway
Link to SmPC in Sweden

Tektrotyd is manufactured by Polatom and is distributed in the Nordic region by SAM Nordic.